Internal Medicine Alert - April 30, 2010

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/10. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Barbara A. Phillips, MD, MSPH
Professor of Medicine,
University of Kentucky;
Director, Sleep Disorders Center,
Samaritan Hospital,
Lexington

Rahul Gupta, MD, MPH, FACP
Clinical Assistant Professor,
West Virginia University
School of Medicine
Charleston, WV

Allan J. Wilke, MD, MA

Professor and Chair
Department of Integrative Medicine
Ross University (Bahamas)
Limited, Freeport, Grand Bahama, The Bahamas

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Author
Ralph R. Hall, MD, FACP, FACSM
Professor of Medicine Emeritus
University of Missouri at Kansas City

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • Muscle Cramp!
  • Would You Do This to Your Mother?
  • Prevent Retail Clinics from Taking Over Your Practice
  • Got Milk!
  • Aztreonam for Inhalation (Cayston┬«)
  • Clinical Briefs by Louis Kuritzky, MD

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, is a consultant for Amylin, Cephalon, Novo Nordisk, Sciele, and Takeda; he receives grant/research support and serves on the speakers bureau of Cephalon and Novo Nordisk. Associate editors Allan J. Wilke, MD, MA, Rahul Gupta, MD, MPH, FACP, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, author Ralph R. Hall, MD, FACP, FACSM, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim. Barbara A. Phillips, MD, MSPH is a retained consultant for Cephalon and Ventus, and serves on the speakers bureaus for Cephalon and Boehringer Ingelheim.

Copyright 2010 AHC Media. All rights reserved.